Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy
- Status
- TERMINATED
- Phase
- PHASE1
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide in Treating Patients With Recurrent High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
- Status
- WITHDRAWN
- Phase
- PHASE1
Temozolomide in Treating Patients With Invasive Pituitary Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2